Free tool
FAERS Monitor: Pegasys
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 103964 or its brand name (Pegasys, Peginterferon Alfa-2a). Reports on generic versions are filed under their own applications.
Reports
53,802
Serious
22,928
43% of reports
Hospitalization
9,508
Death reported
1,801
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue9,266
- nausea7,167
- anaemia6,637
- rash4,877
- headache4,456
- white blood cell count decreased4,232
- pruritus4,227
- pyrexia3,478
- diarrhoea3,388
- vomiting3,338
- asthenia3,152
- insomnia3,079
- dyspnoea3,052
- decreased appetite2,920
- influenza like illness2,741
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 473 |
| 2005 | 1,118 |
| 2006 | 661 |
| 2007 | 655 |
| 2008 | 786 |
| 2009 | 971 |
| 2010 | 1,192 |
| 2011 | 1,492 |
| 2012 | 13,773 |
| 2013 | 8,523 |
| 2014 | 3,095 |
| 2015 | 17,300 |
| 2016 | 869 |
| 2017 | 546 |
| 2018 | 386 |
| 2019 | 326 |
| 2020 | 349 |
| 2021 | 249 |
| 2022 | 301 |
| 2023 | 194 |
| 2024 | 182 |
| 2025 | 213 |
| 2026 | 144 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,357 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| white blood cell count decreasedSignal | 4,232 | 15.8 | 15.4 | 56,828 |
| anaemiaSignal | 6,637 | 14.1 | 13.7 | 78,401 |
| influenza like illnessSignal | 2,741 | 13.4 | 12.9 | 30,601 |
| decreased appetiteSignal | 2,920 | 5.0 | 4.8 | 9,226 |
| fatigueSignal | 9,266 | 4.7 | 4.6 | 27,660 |
| insomniaSignal | 3,079 | 4.6 | 4.4 | 8,565 |
| rashSignal | 4,877 | 4.4 | 4.3 | 12,991 |
| pruritusSignal | 4,227 | 4.3 | 4.2 | 10,929 |
| pyrexiaSignal | 3,478 | 4.0 | 3.8 | 7,740 |
| nauseaSignal | 7,167 | 3.6 | 3.5 | 13,605 |
| astheniaSignal | 3,152 | 3.3 | 3.2 | 5,089 |
| headacheSignal | 4,456 | 2.8 | 2.7 | 5,240 |
| vomitingSignal | 3,338 | 2.8 | 2.7 | 3,886 |
| dyspnoeaSignal | 3,052 | 2.1 | 2.0 | 1,829 |
| diarrhoeaSignal | 3,388 | 2.1 | 2.0 | 1,888 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.